| Functioning Pancreatic Neuroendocrine Tumor studied in …STUDIED_INderived42 of 42show fewer |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001276recruiting Diagnosing and Treating Low Blood Sugar Levels · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808879NA · recruiting Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725693recruiting Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916148available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340437completed Clinical Study of 18F-Exendin-4 in Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735912NA · active not recruiting EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02021604Phase 1 · recruiting Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525082Phase 2 · completed Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04452396NA · terminated CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05523778NA · unknown A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979611Phase 1 · unknown The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431715no longer available 18F-FDOPA PET in Neuroendocrine Tumours · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915144Phase 2 · withdrawn 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034783early Phase 1 · unknown [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229943Phase 2 · completed Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Pancreatic Gastrinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147768Phase 1 · completed Laser Tissue Welding - Distal Pancreatectomy Sealing Study · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Pancreatic Vipoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465659Phase 1/Phase 2 · completed Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Malignant Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189953Phase 1/Phase 2 · completed 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053284Phase 2 · withdrawn Pasireotide in Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185350early Phase 1 · unknown Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03930368NA · unknown Application of Raw Corn Starch on Patients With Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Malignant Pancreatic Gastrinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02108782Phase 2 · withdrawn Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273752Phase 2 · terminated Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560376early Phase 1 · unknown 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937079completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131911Phase 2 · completed Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02121366NA · unknown EUS-guided Ethanol Ablation of an Insulinoma · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075439Phase 2 · completed Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084461Phase 2 · terminated Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005910NA · completed Laparoscopy to Remove Pancreatic Tumors (Insulinomas) · condition mapped ALIAS · 42 trials mapped (7 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |